Cincinnati, OH (PRWEB) January 30, 2008
Cognis Corporation, through its QTA® System business, recently announced that it has successfully developed a BioDiesel Blend Analysis that, in just two minutes, can accurately measure biodiesel percentages in biodiesel-diesel blends. Long known for its ability to accurately test the quality of biodiesel production, the QTA System can now quickly and economically determine the blend percentages for each diesel load leaving a distribution facility.
Barbara Stefl, Global Business Director, said, "Much like the quality testing process currently used in our customer's biodiesel production plants, just a small drop of diesel fuel is all it takes to determine whether the fuel you are selling was properly blended and accurately priced given its biodiesel concentration. And, because the QTA System can measure the blend concentration of a fuel load in just two minutes, you have time to change pricing or adjust the blend percentage before the load leaves the terminal. Our approach does not require a lab or a chemist to operate."
Cognis' QTA patented BioDiesel Blend Analysis starts by digitizing the light spectra of the diesel fuel using proven infrared technology. Those spectra are then sent, via the internet, to Cognis' central database where algorithms converts the spectra, in real-time, into standard quality measurements or percentage measurements that are viewed online. All this occurs in less than two minutes.
Cognis' QTA system is offered on a subscription basis and does not require any capital investment. The monthly subscription includes an easy-to-use infrared spectrometer, software for a standard PC and unlimited use of Cognis' Chingometric™ centrally-calibrated algorithms that covert the light spectra into actionable information.
Cognis QTA will be conducting real-time demonstrations of its new BioDiesel Blend and its BioDiesel Quality Testing System at the National BioDiesel Conference & Expo on February 3-6 in Orlando, Florida.
QTA® is a service business of Cognis Corporation -a worldwide supplier of innovative specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability. The company employs about 7,700 people, and it operates production sites and service centers in 30 countries. Cognis' QTA® business provides on-site, ready-to-use analytical capabilities without additional investment in equipment or personnel. Patented, centralized calibration technology enhances accuracy. For more information on the QTA® system, visit http://www.qta.com .
Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2006, Cognis recorded sales of 3.37 billion euros and an Adjusted EBITDA (operating result) of 394 million euros.
# # #